Myomancy ADHD, Dyslexia and Autism

An advisory panel to the U.S. Food & Drug Administration has voted by a narrow majority to add a ‘black box’ warning to methylphenidates such as Ritalin, Concerta, Methylin and Metadate. This follows the deaths of 19 children and six adults being linked to the drugs which are used by over 2 million children a year. Currently Adderall has a warning telling patients with heart conditions not to use the drug and Strattera has a black-box warning that it may prompt suicidal thoughts in children.
Drug Safety and Risk Management Advisory Committee, FDA Panel Calls for Strongest Warning on ADHD Drugs
Previously on Myomancy: Strattera Suicide Risk, Are ADHD drugs safe?, Adderall: Benefits and Side-Effects, FDA Concerns Over ADHD Drug Concerta